Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changsha Hairun Biotechnology is a China-based medical technology and healthcare products company focused on wound repair, skin tissue engineering management, scar management, aesthetic recovery, and related diagnostic and protective products. The company develops, manufactures, and sells medical dressings, wound-care devices, scar-management products, point-of-care testing products, and clinical chemistry reagents. Its business appears to be centered on commercialized Class II/III medical devices and consumables rather than a traditional therapeutic drug pipeline. Hairun operates manufacturing and R&D facilities in Changsha and has highlighted capabilities including clean-room production, clinical testing support, and ISO 13485 quality certification. The company serves hospitals and medical institutions in China and also appears to sell internationally through export channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changsha Hairun Biotechnology.